Kymanox

Welcome Our Newest Quality Team Members! Please join us in welcoming 𝗛𝗮𝗻𝗻𝗮𝗵 and 𝗔𝗹𝗲𝘅𝗮𝗻𝗱𝗿𝗮! Both bring valuable expertise that will help strengthen our quality initiatives. Comment below to say "Hello!" Hannah Mitchell - 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘦 𝘘𝘶𝘢𝘭𝘪𝘵𝘺 𝘌𝘯𝘨𝘪𝘯𝘦𝘦𝘳 "As a young professional new to Kymanox, it has been amazing getting to learn from and work with kind and caring people who are passionate about their work. It is great to know that I am part of an organization that brings out the best in its employees and invests in their learning, personal, and professional development." Alex Robertson - 𝘘𝘶𝘢𝘭𝘪𝘵𝘺 𝘚𝘱𝘦𝘤𝘪𝘢𝘭𝘪𝘴𝘵 "As my journey begins at Kymanox, I've found nothing but wonderful people at every turn. Everyone has been incredibly welcoming and helpful during my start. I'm so excited to learn and grow with the Kymanox team, and look forward to see what the future holds!" Hannah and Alex, we're excited to have you join us! #pharma #lifesciences #newhires --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Can large-volume subcutaneous drug delivery reshape patient care? Many believe 1 mL is the limit for subcutaneous injection. The reality is that we are now seeing successful 10 to 20 mL administrations without permeation enhancers. Tune in with Hanns-Christian Mahler, Founder & CEO of ten23 health, and guest host, Mathias Romacker as they challenge conventional wisdom and explore the future of biologics delivery. Watch on YouTube: https://lnkd.in/ezrceZus --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Avoid costly regulatory setbacks in Biologics Manufacturing. Warning Letters often cite contamination risks, inadequate data trending, and poor risk assessments—leading to delays, remediation costs, and compliance hurdles. At Kymanox, our team of industry experts brings hands-on experience in GMP compliance, regulatory strategy, and large-scale manufacturing to help biologics companies stay inspection-ready. From training and risk assessments to contamination control and EU Annex 1 compliance, we ensure your processes meets the highest standards. Connect with our team: Nicole Bridgers | Anthony Stewart | LeAnne Adkins | Kyle Arend, PhD | Jordan Bischoff, MMB | Anthony Winner | Ciony Kim #Biologics #ATMP #GeneTherapy #GMP #PharmaceuticalManufacturing --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Attention #Cellangene Innovators: Are you attending the upcoming #FDA Webinar tomorrow, Tuesday, 25 February 2025? Don't miss out on "Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development." The purpose of the workshop is to explore the latest in science, development, and regulation of cellular therapies and tissue-based products. Learn more at https://lnkd.in/ePidi2be #genetherapy #celltherapy --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

February is Black History Month, and we're proud to highlight Dr. Kizzmekia S. Corbett-Helaire, PhD, a North Carolina native and pioneering immunologist whose groundbreaking work was instrumental in developing mRNA vaccine technology. After earning her Ph.D. from UNC Chapel Hill, Dr. Corbett led the NIH team that designed the immunological foundation for COVID-19 mRNA vaccines. Today, she continues to advance the field of immunology as an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health. Dr. Corbett's innovative research has not only saved countless lives but also opened new frontiers in vaccine development. As a passionate advocate for scientific literacy and diversity in STEM, she works tirelessly to ensure that scientific advancements reach all communities equitably. Her commitment to both scientific excellence and public education makes her an inspiring role model for future generations of scientists. At Kymanox, we celebrate the extraordinary contributions of Black innovators in life sciences and remain committed to fostering diversity, equity, and innovation in healthcare. Their achievements remind us that breakthrough innovations come from diverse perspectives and inclusive environments. Who are the Black scientists and leaders who have inspired you? Share their stories in the comments below! #BlackHistoryMonth #Innovation #LifeSciences #STEM #Diversity

When a biopharma company needed a phase-appropriate Continued Process Verification (CPV) protocol for their bioconjugate drug substance at a CDMO, they turned to Kymanox. Our mission was to ensure commercial manufacturing readiness while reducing operational risks. 𝗧𝗵𝗲 𝗜𝗺𝗽𝗮𝗰𝘁: ✅ Successfully implemented a comprehensive CPV program ✅ Minimized operational risk ahead of commercial batches ✅ Strengthened process control & regulatory compliance ✅ Expanded client collaboration into additional technical areas Kymanox was proud to provide technical project leadership and process oversight, ensuring our client was set up for success in commercial manufacturing. Need support with CPV implementation? Connect with our team of experts: Nicole Bridgers | Anthony Stewart #CPV #GMP #PharmaceuticalManufacturing #Bioconjugates #QualityControl #CDMO

This week on Life Science Solutions: Hanns-Christian Mahler shares his journey from industry leader to founder of ten23 health, a rapidly growing #CDMO powering #biologics development. Together with guest host, Mathias Romacker, they explore changing industry dynamics since 2017, from subcutaneous delivery advances to partnership evolution. Featured clip: Hanns-Christian discusses how fragmented partnerships impact development timelines. Connect with Kymanox to streamline your path from design to development. #LifeSciences #BiologicsManufacturing --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Join us in one week at ISPE-CaSA's 32nd Annual Tech Show! Stop by Booth #415 to meet our team and explore how we can support your drug development, manufacturing, and regulatory initiatives. 📅 Date: February 25, 2025 📍 Location: Raleigh Convention Center 🎯 Booth #415 Let’s connect! Schedule a meeting with our experts to discuss your specific needs and discover how we can help accelerate your projects. Chris Adkins | Corey Marshall | Kevin C. Brown, PMP | Jenny Wieboldt

Kymanox is #hiring! We’re looking for a Senior Director, Quality Leader to join our team in RTP, NC. This is an exciting opportunity to lead our Quality department while providing quality oversight for key projects and initiatives. If you have experience with #pharma, #medicaldevices, #combinationproducts, and #quality development, we encourage you to apply! We also have several other exciting opportunities available—visit our careers page to explore open roles and find the right fit for you. Apply now: https://lnkd.in/efSpr6Kf --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Pharmapack 2025: Dive into our key takeaways from #Pharmapack2025, co-authored by Taras Seniuch, Senior Director, Global Business Development, Kymanox and Michael McGowan, Head of Business Development Europe, SHL Medical. Pharma is evolving fast—high-volume #injectables, #sustainability, and strategic partnerships are reshaping the landscape. At Kymanox, we saw firsthand that speed to market, regulatory success, and commercialization are accelerated by strategic collaboration. What’s next for drug delivery? Tell us in the comments! Click below to find out.https://https://lnkd.in/ggC_MVtX --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv